Memphasys Ltd has released a press release.
$3.36 capital raising to accelerate FELIX commercialisation
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Memphasys
- Suspension from Official Quotation
- Monash IVF clinical study enrols first patient using FELIX
- Felix System commercialisation update
- Follow up sales of FelixTM System
- MEM Achieves ISO 13485 Compliance
Later from Memphasys
- Rights Issue Closure and Shortfall Notification
- FELIX System commercialisation, regulatory plan and trial
- KOL testings demonstrate Felix System outperforms DGC
- Japan first commercial sale and first baby born using Felix
- Felix considered best method to treat cryopreserved semen
Follow Memphasys into a list and get an email when it puts out news.
Follow Memphasys